WASHINGTON -- The Senate won't vote until early next year on a bill to loosen restrictions on publicly funded embryonic stem cell studies, under a deal struck Friday by the sponsors.
The bill is controversial because the research process destroys fertilized human embryos, which some people believe is immoral. The House passed the measure in May and it is expected to win a majority in the Senate. Neither chamber has enough votes to override Mr. Bush's promised veto.
Embryonic stem-cell studies have the support of a majority of Americans in part because the research holds great promise in the search for treatments and cures for such diseases as Alzheimer's, Parkinson's, diabetes and cancer.
http://users1.wsj.com/lmda/do/checkLogin?a=t&d=wsj&sd=users1&url=http%3A%2F%2Fonline.wsj.com%2Farticle%2FSB112990793729675747.html%3Fmod%3Dpolitics_primary_hs